Home
Life Sciences
Healthcare
Rx to OTC Switches 2009

Healthcare

Summary

Table of Contents

Rx to OTC Switches 2009

Publication date: April 2009

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products.
The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.

As part of its coverage, this report includes

Current Market for Rx to OTC across major categories

Past Results of OTC Switches

Products Most Likely to Switch to OTC

Assessment of the Economic Downturn's Impact

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:

Allergy, Cough, Cold, and Sinus Products

Analgesics, NSAIDs, and Pain Treatments

Anti-Infectives

Gastrointestinal Drugs

Hair Loss Products

Hormones

Oral Care

Rectal Ointments

Sleep-aids

Smoking Cessation

Weight Loss

In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include:

Cholesterol-reducing Drugs

Osteoporosis Treatments

Overactive Bladder

Sexual Dysfunction

The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug. Current and historical revenues for product segments include both the switched brands and OTC drugs containing switched ingredients. Forecasted data includes current products and forecasted switches which are outlined in the report.

The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

Healthcare Industry in the United States

Table of Contents
List of Exhibits
Chapter One: Executive Summary: Scope and Methodology; Size and Growth of the Market; Issues and Trends Affecting the Rx-to-OTC Switches Market; Leading Competitors
Chapter Two
Introduction: Overview of the Over-the-Counter Market; Development of the Rx-to-OTC Drug Market; Rx-to-OTC Industry Structure
Chapter Three
Allergy, Cough, Cold, and Sinus Products: Overview; Description of Conditions; Prevalence and Incidence; Product Analysis; Market Analysis
Chapter Four
Analgesics and Other Pain Relievers: Overview; Description of Conditions; Prevalence and Incidence; Product Analysis; Market Analysis
Chapter Five
Anti-infectives: Overview; Description of Conditions; Prevalence and Incidence; Product Analysis; Market Analysis
Chapter Six
Gastrointestinal Drugs: Overview; Description of Conditions; Prevalence and Incidence; Product Analysis; Market and Competitive Analysis
Chapter Seven
Smoking Cessation: Overview; Description of Conditions; Prevalence and Incidence; Product Analysis; Market Analysis
Chapter Eight
Other Drug Classifications: Overview; Description of Conditions; Conditions with Possible Future OTC Treatments; Prevalence and Incidence; Product Analysis; Market Analysis
Chapter Nine
Total Market Summary: Overview; Total market Size and Forecast; Competitive Analysis; Market Analysis
Chapter Ten: Issues and Trends Affecting the Rx-to-OTC Market: Introduction; Regulatory Authorities; A Third Class of Drug; Insurance Issues and Reimbursement for OTC Drugs; Impact on the Consumer; Pharmacists Role; Impact on the Prescription Drug Manufacturer; Strategies for Continued Product Growth; Patent Expiration; Labeling Changes; International Trends in Rx-to-OTC Switches
Chapter Eleven: Company Profiles: Introduction; GlaxoSmithKline; Johnson & Johnson; Novartis; Procter & Gamble; Schering-Plough; Wyeth
APPENDIX: Company Directory
Table of Contents
List of Exhibits
Chapter One
Executive Summary: Table 1-1 - The U.S. Market for Rx-to-OTC Switches 2004-2013; Compound Annual Growth Rate; Figure 1-1 - The U.S. Market for Rx-to-OTC Switches, 2004-2013
Chapter Two
Introduction: Table 2-1 - OTC Retail Sales, 1976-2007; Table 2-2 - Rx-to-OTC Switches Approved by the FDA 1976-2007; Figure 2-1 - Number of New Rx-to-OTC Switches per Year 1976-2007; Table 2-3 - Statistics for Selected Rx-to-OTC Switches (United States); Table 2-4 - Estimated OTC Sales by Product Type and Percent of Sales Attributed to Rx-to-OTC Switched Ingredients; Table 2-5 - U.S. Population by Sex and Selected Age Group, 1997-2017; Figure 2-2 - U.S. Population by Sex, 1997-2017; Figure 2-3 - U.S. Population by Selected Age Group, 1997-2017; Table 2-6 - Healthcare Industry Inflation Rates Healthcare Industry Consumer Price Index Comparisons Based on 2008 Data; Figure 2-4 - Healthcare Industry Inflation Rates Healthcare Industry Consumer Price Index Comparisons Based on 2008 Data
Chapter Three
Allergy, Cough, Cold, and Sinus Products: Table 3-1 - United States Incidence of Allergy, Cough, Cold, Sinus Conditions 2008; Figure 3-1 - United States Incidence of Allergy, Cough, Cold, Sinus Conditions, Superimposed on Total Population, 2008; Table 3-2 - Allergy, Cough, Cold, Sinus Product Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 3-3 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 3-4 - The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 2004-2008; Compound Annual Growth Rate; Table 3-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 2009-2013; Compound Annual Growth Rate; Figure 3-2 - The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 2004-2013; Figure 3-3 - The U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, by Percent and Product Type, 2008; Table 3-6 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2008; Figure 3-4 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2008
Chapter Four
Analgesics and Other Pain Relievers: Table 4-1 - United States Incidence of Conditions with Pain and Inflammatory Symptoms 2008; Figure 4-1 - United States Incidence of Conditions with Pain and Inflammatory Symptoms Superimposed on Total Population, 2008; Table 4-2 - Analgesics, NSAIDs and Other Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 4-3 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 4-4 - The U.S. Market for Rx-to-OTC Switches Analgesic Product Revenues 2004-2008; Compound Annual Growth Rate; Table 4-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Analgesic Product Revenues 2009-2013; Compound Annual Growth Rate; Figure 4-2 - The U.S. Market for Rx-to-OTC Switches Analgesic Product Revenues 2004-2013; Figure 4-3 - The U.S. Market for Rx-to-OTC Switches: Analgesic Product Type, 2008; Table 4-6 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Analgesics 2008; Figure 4-4 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Analgesics 2008
Chapter Five
Anti-infectives: Table 5-1 - United States Yearly Incidence of Infections, 2008; Figure 5-1 - United States Yearly Incidence of Infections Superimposed on Total Population, 2008; Table 5-2 - Anti-infectives Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 5-3 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 5-4 - The U.S. Market for Rx-to-OTC Switches Anti-infective Product Revenues 2004-2008; Compound Annual Growth Rate; Table 5-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Anti-infective Product Revenues 2009-2013; Compound Annual Growth Rate; Figure 5-2 - The U.S. Market for Rx-to-OTC Switches Anti-infective Product Revenues 2004-2013; Figure 5-3 - The U.S. Market for Rx-to-OTC Switches: Anti-infective Product Type, 2008; Table 5-6 - Leading Suppliers’ Shares of The U.S. Market for Rx-to-OTC Switched Anti-infectives 2008; Figure 5-4 - Leading Suppliers’ Shares of The U.S. Market for Rx-to-OTC Switched Anti-infectives 2008
Chapter Six
Gastrointestinal Drugs: Table 6-1 - United States Incidence of Gastrointestinal Conditions 2008; Table 6-2 - Gastrointestinal Drug Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 6-3 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 6-4 - The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drug Revenues 2004-2008; Compound Annual Growth Rate; Table 6-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Gastrointestinal Drug Revenues 2009-2013; Compound Annual Growth Rate; Figure 6-2 - The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drug Revenues 2004-2013; Figure 6-3 - The U.S. Market for Rx-to-OTC Switches: Gastrointestinal Drug by Product Type, 2008; Table 6-6 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 2008; Figure 6-4 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 2008
Chapter Seven
Smoking Cessation: Table 7-1 - United States Cigarette Usage in Percent by Age Group, 2006; Figure 7-1 - New Lung Cancer Cases and Deaths for 2008 by Gender, United States; Table 7-2 - New Cases of Lung and Bronchus Cancer by State; Deaths from Lung and Bronchus Cancer by State, 2008 Estimates; Table 7-3 - Smoking Cessation Product Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 7-4 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 7-5 - The U.S. Market for Rx-to-OTC Switches Smoking Cessation Product Revenues 2004-2008; Compound Annual Growth Rate; Table 7-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Smoking Cessation Product Revenues 2009-2013; Compound Annual Growth Rate; Figure 7-2 - The U.S. Market for Rx-to-OTC Switches Smoking Cessation Product Revenues 2004-2013; Figure 7-3 - The U.S. Market for Rx-to-OTC Switches: Smoking Cessation Product Type, 2008; Table 7-8 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 2008; Figure 7-5 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 2008
Chapter Eight
Other Drug Classifications: Table 8-1 - United States Incidence of Miscellaneous Conditions for Which There Are Potential Rx-to-OTC Switches 2008; Table 8-2 - Estimated U.S. Contraceptive Use by Method, Five Year Average 2007/2008; Table 8-3 - Miscellaneous Drug Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval; Table 8-3 - Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity; Table 8-4 - The U.S. Market for Rx-to-OTC Switches Other Drug Classification Product Revenues 2004-2008; Compound Annual Growth Rate; Table 8-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Other Drug Classification Product Revenues 2009-2013; Compound Annual Growth Rate; Figure 8-2 - The U.S. Market for Rx-to-OTC Switches Other Drug Classification Product Revenues 2004-2013; Table 8-6 - The U.S. Market for Rx-to-OTC Switches Other Drug Classifications Revenues by Product Type 2004-2013; Compound Annual Growth Rate; Figure 8-3 - The U.S. Market for Rx-to-OTC Switches Other Drug Classifications Revenues by Product Type 2004-2013; Figure 8-4 - The U.S. Market for Rx-to-OTC Switches Other Drug Classifications Distribution of Revenues by Product Type 2008; Table 8-7 - Leading Suppliers’ Shares of the U.S. Market for Rx-to-OTC Switches Other Drug Classifications 2008; Figure 8-5 - Leading Suppliers’ Shares of the U.S. Market for Rx-o-OTC Switches Other Drug Classifications 2008
Chapter Nine
Total Market Summary: Table 9-1 - The U.S. Market for Rx-to-OTC Switches 2004-2013; Compound Annual Growth Rate; Figure 9-1 - The U.S. Market for Rx-to-OTC Switches, 2004-2013; Markets by Segments; Figure 9-2 - The U.S. Market for Rx-to-OTC Switches by Product Category, 2004-2013; Figure 9-3 - The U.S. Market for Rx-to-OTC Switches, Distribution of Revenues by Product Category 2008; Table 9-4 - Leading Suppliers Significant Segments of Participation within the U.S. Market for Rx-to-OTC Switches, 2008; Figure 9-4 - Leading Suppliers Market Share in the U.S. Market for Rx-to-OTC Switches, 2008
Chapter Ten : Issues and Trends Affecting the Rx-to-OTC Market: Table 10-1: Health Insurance Trends in the United States 2003-2006; Table 10-2: National Healthcare Expenditures in the United States 1960-2010; Figure 10-1: Healthcare Spending as a Percent of GDP in the United States; Figure 10-2: Internet Users per 100 Inhabitants, 1994-2006; Table 10-3:Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006; Figure 10-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006; Table 10-4: Average Annual Expenditures per Consumer Unit for Healthcare 2004-2006; Figure 10-4: Typical Pharmacist-Consumer OTC Drug Counseling Session; Table 10-5: U.S. Patent Expirations for Select Prescription Pharmaceuticals; Table 10-6: Legal Classification Status of Selected Ingredients Worldwide; Table 10-7: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007; Figure 10-5: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007; Table 10-8: Average Life Expectancy in Years by Country 1980 and 2008; Figure 10-6: Average Life Expectancy in Years by Country 1980 and 2008; Table 10-9: World Population 1980 to 2050; Figure 10-7: World Population 1980 to 2050; Table 10-10: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010; Figure 10-8: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Healthcare Industry in the United States : Latest Reports

Tacrolimus - Comprehensive patent search

$ 7 270
Industry report
May 2012
by GenericsWeb

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not ...

Global Markets for Telemedicine Technologies

$ 4 850
Industry report
March 2012
by BCC Research

INTRODUCTION STUDY GOALS AND OBJECTIVES This is an update of an earlier BCC report (Jan. 2011). BCC's goal in updating the report is to assess the impact of recent technical, economic, legal/regulatory, ...

Home Healthcare Market (Equipment, Service & Telehealth/Telemedicine) Current Trends, Opportunities & Global Forecasts to 2016

$ 4 650
Industry report
April 2012
by MarketsandMarkets

Home Healthcare Market (Equipment, Service & Telehealth/Telemedicine) Current Trends, Opportunities & Global Forecasts to 2016 Home healthcare includes support and care services and devices which are provided ...

Global Medical Nonwoven Disposables Indust ...

March 2012 $ 4 500

Pricing And Reimbursement In Generics - Eu ...

April 2012 $ 3 500

Electronic Medical Records Market To 2017 ...

March 2012 $ 3 500

Healthcare Providers: Global Industry Alma ...

February 2012 $ 2 995

Mobile Health Devices And Applications - G ...

April 2012 $ 2 000

Forecast Revisit From 2011 To 2012 : Consu ...

February 2012 $ 1 995

Global Picture Archiving And Communication ...

March 2012 $ 1 500

More Reports:

Healthcare in Australia (56)

Healthcare in Brazil (49)

Healthcare in China (88)

Healthcare in France (54)

Healthcare in India (82)

Healthcare in Russian Federation (45)

Healthcare in the United Kingdom (48)

Healthcare in the United States (220)

Company Reports

Management Strategies

Natural Solutions Magazine

AGFA Healthcare

AllScripts-Misys Healthcare Solutions In ...

Robert Bosch Corp.

McKesson Corp.

Kao Corp.

Lilly And Co.

Bayer AG

Sony Corp.

Healthcare Industry in the United States : Latest Downloads

Healthcare Market

Industry report
May 2012
14 pages
by Intergovernmental Agency

... How The building blocks that must be in place to realize the vision ehealth components value of a national approach Engage multi-sector stakeholders around health priorities and public health ...

Managed Care Business Overview

Industry report
May 2012
38 pages

... Happen at a retail/consumer level on an insured basis Facilitate the movement to a defined contribution model Mitigate trend to support a compensation-like rate of increase Treat health benefits ...

Hospital Market Overview

Industry report
May 2012
45 pages

... To maintain optimal health and function while they are hospitalized, so that they can transition successfully home or to the next appropriate level of care Organizational support Leadership and support ...